ALKAMAX MB6 SYRUP 450 ML

ALKAMAX MB6 Syrup is commonly used to treat urinary tract infections (UTIs), kidney stones, and gout. It works by alkalinizing the urine, which helps dissolve kidney stones and reduces bacterial growth in UTIs.

The main ingredients in ALKAMAX MB6 Syrup typically include Disodium Hydrogen Citrate, Magnesium Citrate, and Vitamin B6 (Pyridoxine).

Common side effects of ALKAMAX MB6 Syrup may include nausea, vomiting, diarrhea, and stomach upset. Consult a doctor if any of these side effects persist or become severe.

ALKAMAX MB6 Syrup should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children.

It is important to consult a doctor before using ALKAMAX MB6 Syrup during pregnancy. They can advise you whether it is safe for you.

It is important to consult a doctor before using ALKAMAX MB6 Syrup during breastfeeding. They can advise you whether it is safe for your baby.

It is generally better to take ALKAMAX MB6 Syrup after food to reduce the chance of stomach upset.

The dosage of ALKAMAX MB6 Syrup is determined by the doctor. Please follow your doctor's instructions.

ALKAMAX MB6 Syrup can interact with certain medications. Therefore, inform your doctor about all your medications.

The time it takes for ALKAMAX MB6 Syrup to work can vary from person to person.

If you miss a dose of ALKAMAX MB6 Syrup, take it as soon as possible. If it is time for your next dose, skip the missed dose and continue with your regular schedule.

Yes, ALKAMAX MB6 Syrup can help prevent kidney stones by alkalinizing the urine, which reduces the likelihood of stone formation.

ALKAMAX MB6 Syrup can help relieve the symptoms of UTIs, but it does not treat the infection itself. Antibiotics are needed to treat a UTI.

Overdosing on ALKAMAX MB6 Syrup can lead to electrolyte imbalances and other health problems. Always follow the dosage prescribed by your doctor.

It is essential to consult a doctor before giving ALKAMAX MB6 Syrup to children. The dosage and safety should be determined by a doctor.

Alkamax syrup is generally used as a urinary alkaliniser and stone-preventive agent in patients with recurrent kidney stones, especially calcium oxalate or uric acid stones, and in those with documented low urinary citrate (hypocitraturia). By increasing urinary citrate and raising urinary pH, it helps reduce the risk of new stone formation and may slow the growth of existing small stones. It is prescribed by a doctor after evaluation of the patient’s stone type and metabolic profile.

Alkamax syrup typically contains potassium citrate and magnesium citrate, which act as systemic alkalinisers. After absorption, these citrate salts are metabolised to bicarbonate, leading to an increase in urinary pH and urinary citrate levels. Higher citrate levels bind calcium in the urine, reducing the formation of calcium oxalate and calcium phosphate crystals. The alkalinisation of urine also makes conditions less favourable for uric acid stone formation. Pyridoxine (vitamin B6) may further help reduce endogenous oxalate production in some individuals, providing an additional protective effect against calcium oxalate stones.

Alkamax syrup should not be taken without medical supervision. Although it may appear to be a simple alkalinising or vitamin-containing product, it can significantly alter electrolyte balance and urinary chemistry. Inappropriate use may lead to complications such as hyperkalaemia, hypermagnesaemia, or worsening of underlying kidney or cardiac conditions. A healthcare professional should first confirm the indication, review your medical history and current medications, and then determine whether Alkamax syrup is appropriate for you.

The exact dose, frequency, and duration of Alkamax syrup must be determined by your doctor based on your clinical condition, laboratory results, and urinary pH or citrate levels. In general, it is taken orally, usually with or after meals to reduce gastrointestinal discomfort. Some clinicians may advise dividing the total daily amount into two or more doses. You should carefully follow the dosing instructions on the prescription label and avoid altering the dose or schedule on your own. If you have any doubts about how to take it, consult your prescriber or pharmacist.

Common side effects associated with citrate-based alkalinising syrups such as Alkamax include mild gastrointestinal symptoms like nausea, abdominal discomfort, bloating, diarrhoea, or a feeling of fullness. Some patients may notice a salty or slightly unpleasant taste. These effects are often dose-related and may improve if the syrup is taken with food. If gastrointestinal symptoms are persistent, severe, or associated with vomiting, you should contact your doctor. Any signs of muscle weakness, palpitations, or unusual tiredness should also be reported promptly, as they may indicate electrolyte disturbances.

Alkamax syrup is generally contraindicated or should be used with great caution in patients with significant renal impairment, anuria, untreated Addison’s disease, severe dehydration, uncontrolled diabetes with hyperkalaemia, or known hyperkalaemia or hypermagnesaemia. It may also be unsuitable for individuals with certain types of kidney stones, such as those associated with infection, unless specifically advised by a specialist. Patients taking potassium-sparing diuretics, ACE inhibitors, angiotensin receptor blockers, or other potassium supplements require careful monitoring if Alkamax is prescribed. Always inform your doctor about all existing medical conditions before starting therapy.

Safety data for Alkamax syrup as a fixed combination in pregnancy are limited. Its components—potassium citrate, magnesium citrate, and pyridoxine—have been used individually in pregnancy when clearly indicated, but any alkalinising therapy that alters electrolyte balance should be prescribed cautiously. If you are pregnant or planning to become pregnant, you should not start or continue Alkamax syrup without explicit advice from your obstetrician or treating specialist. The potential benefits in preventing recurrent stones must be weighed against possible risks, and monitoring of electrolytes and renal function may be required.

Information on the use of Alkamax syrup specifically during breastfeeding is limited. Pyridoxine is generally considered compatible with breastfeeding at usual therapeutic doses, and small amounts of potassium and magnesium are normally present in breast milk. However, because Alkamax syrup can influence maternal electrolyte balance and acid–base status, it should only be used in lactating women under medical supervision. Your doctor will assess the necessity of therapy, your renal function, and any potential risks to the breastfed infant before recommending its use.

Yes, Alkamax syrup can interact with several medications. The potassium component may increase the risk of hyperkalaemia when used with potassium-sparing diuretics (such as spironolactone, eplerenone, or amiloride), ACE inhibitors, angiotensin receptor blockers, certain nonsteroidal anti-inflammatory drugs, or other potassium supplements. Magnesium salts can interact with some antibiotics (for example, certain tetracyclines and fluoroquinolones) by reducing their absorption if taken at the same time. Alkalinisation of urine can also affect the excretion of drugs that are weak acids or bases. You should provide your doctor and pharmacist with a complete list of all prescription medicines, over-the-counter products, and herbal supplements you are taking before starting Alkamax syrup.

If you miss a dose of Alkamax syrup, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for the missed one, as this may increase the risk of gastrointestinal upset or electrolyte imbalance. If you frequently forget doses, discuss this with your doctor; they may suggest strategies to improve adherence or consider alternative treatment options.

The duration of Alkamax syrup therapy varies depending on the underlying cause of stone formation, your metabolic profile, and your response to treatment. Some patients may require therapy for several months, while others with recurrent or high-risk stone disease may need longer-term management. Your doctor will periodically reassess your symptoms, imaging findings, and laboratory results (including urinary pH, citrate excretion, and serum electrolytes) to decide whether to continue, adjust, or discontinue the medication. You should not stop treatment abruptly without consulting your healthcare provider, as this may increase the risk of stone recurrence.